Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Accounts Payable & Accrued Expense : $4.28 Mil (As of Dec. 2018)

View and export this data going back to 2014. Start your Free Trial

What is Parnell Pharmaceuticals Holdings Accounts Payable & Accrued Expense?

Parnell Pharmaceuticals Holdings's quarterly accounts payable & accrued expense declined from Dec. 2016 ($5.75 Mil) to Dec. 2017 ($4.94 Mil) and declined from Dec. 2017 ($4.94 Mil) to Dec. 2018 ($4.28 Mil).

Parnell Pharmaceuticals Holdings's annual accounts payable & accrued expense declined from Dec. 2016 ($5.75 Mil) to Dec. 2017 ($4.94 Mil) and declined from Dec. 2017 ($4.94 Mil) to Dec. 2018 ($4.28 Mil).

Parnell Pharmaceuticals Holdings Accounts Payable & Accrued Expense Historical Data

The historical data trend for Parnell Pharmaceuticals Holdings's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Parnell Pharmaceuticals Holdings Accounts Payable & Accrued Expense Chart

Parnell Pharmaceuticals Holdings Annual Data

Trend

Jun12

Jun13

Jun14

Dec15

Dec16

Dec17

Dec18

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

3.87

4.90

5.75

4.94

4.28

Parnell Pharmaceuticals Holdings Semi-Annual Data
	Jun12	Jun13	Jun14	Dec15	Dec16	Dec17	Dec18
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial			3.87	4.90	5.75	4.94	4.28

Parnell Pharmaceuticals Holdings Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Parnell Pharmaceuticals Holdings (Parnell Pharmaceuticals Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Parnell Pharmaceuticals Holdings Ltd (OTCPK:PARNF) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

476 Gardeners Road, Unit 4, Century Estate, Alexandria, Sydney, NSW, AUS, 2015

Website

https://www.parnell.com

Parnell Pharmaceuticals Holdings Ltd is an Australia based veterinary pharmaceutical company. It is focused on developing, manufacturing and commercializing animal health solutions. The group manufactures and market products for companion animals and production animals. The firm also has a pipeline of drug products like Zydax, PAR121 and PAR122 and Luminous which covers therapeutic areas in orthopedics, dermatology, and nutraceuticals. The operating segments of the company are Companion animal, Production animal - U.S., Production animal - rest of world and Contract Manufacturing. It operates internationally and generates the majority of the revenue from the Production animal - U.S. segment which covers the group's reproductive hormone portfolio across production animal in the USA.